Davita Calls Whistleblowers' FCA Kidney Drugs Suit Flawed
By Linda Chiem · August 15, 2014, 3:24 PM EDT
Davita Inc. urged a Georgia federal court on Thursday to toss a whistleblower suit alleging it bilked taxpayers by seeking reimbursement for intentionally overused or wasted dialysis drugs, saying its dosing...
To view the full article, register now.